Ignite Creation Date:
2024-05-06 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03556228
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2018-04-29
Brief Title:
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Sponsor:
VM Oncology LLC
Organization:
VM Oncology LLC
Organization Data
Organization:
VM Oncology LLC
Class:
INDUSTRY
Study ID:
VMO-01C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
VM Oncology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None